Diabetes in India - The Rise of the Sweet Epidemic

Dec 8,2020 | Healthcare Services

Diabetes is a disease that causes high blood sugar. Speaking in medical terms, diabetes causes a decline in the production of insulin, which is a vital component to move the sugar from the blood into our cells to be stored as energy. Although it is a fact that consuming large amounts of sugar in any form triggers the risk of diabetes, it is still just one aspect of the cause. An unhealthy diet and increasing obesity rates, as well as a stressful lifestyle and genetics also form a major part of the risk factor.

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined. The Indian diabetes market reached a value of US$ 1,954 Million in 2018. The market is further expected to grow at a CAGR of 16.7% during 2019-2024.

The detailed report offered by Bharatbook on the aforementioned topic provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

To gain more insights on the market, please visit Indian Diabetes Market.